MIRA PHARMACEUTICALS, INC. (MIRA) AI Dilution Summary

Estimated cash was $3,609,442 as of 2026-06-30, matching cash at that balance-sheet date, against estimated monthly burn of $401,863. The company funds itself through its active ATM with Rodman & Renshaw LLC, authorised to $75,000,000, with 5,913,369 shares sold since the program began through 2026-06-30; sales after 2026-06-30 are not yet reported.